DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Small Molecule Drugs cited in Purdue Pharma L.P. v. IMPAX Laboratories, Inc.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2011-04-08||1||States Patent l\lo. 7,776,314 entitled “ABUSE-PROOFED DOSAGE SYSTEl\/l" (“the ’314 patent”), including…and an exclusive licensee of United States Patent No. 7,776,314 identified in paragraph 19 below. Purdue…Grunenthal is the owner of United States Patent No. 7,776,314 identified in paragraph 19 below. THE PARTIES…the ’3l4 patent from Grtlnenthal, with the right to enforce the ’314 patent. The 7314 patent is listed…ACTION l. This is an action for patent infringement arising under the patent laws Of the Unitcd States, &||External link to document|
|2013-09-10||110||invention date for the claims of U.S. Patent No. 6,488,963 Patent that is earlier than June 26, 1996; 2… 2. Plaintiffs stipulate that European Patent Application 0 661 045 ("the EP '045 Publication") was published…1995, and is prior art to the claims of the '963 Patent under 35 U.S.C. § 102(a); 3. and Plaintiffs will…the EP '045 Publication is prior art to the '963 Patent at trial. (Signed by Judge Sidney H. Stein on 9…2011 6 December 2013 1:11-cv-02400 830 Patent None District Court, S.D. New||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|